Leverage Single-Cell Multi-Omics for a Comprehensive Understanding of AML, PDX Model Validation, and Therapeutic Development

Time: 12:00 pm
day: Applications for Efficacy Evaluation & Biomarker Discovery Day 1 AM


  • Case studies leveraging single-cell DNA + protein multi-omics to understand AML disease evolution, treatment response, and mechanisms of resistance.
  • How PDX models and sample multiplexing were used for baseline and end-point analysis in AML samples. 
  • Introducing a novel single-cell multiomics approach to dissect disease models, reduce downstream clinical trial costs and failure rates.